Skip to main content
Clinical Trials/NCT04468932
NCT04468932
Recruiting
Not Applicable

Cerebellar Transcranial Magnetic Stimulation for Motor Control in Progressive Supranuclear Palsy

Oregon Health and Science University1 site in 1 country30 target enrollmentJanuary 17, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Palsy Supranuclear
Sponsor
Oregon Health and Science University
Enrollment
30
Locations
1
Primary Endpoint
objective posturography
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural instability in patients with PSP. We will use functional near infrared spectroscopy (fNIRS) to examine changes in motor and premotor cortical activity after cerebellar rTMS.

Registry
clinicaltrials.gov
Start Date
January 17, 2020
End Date
April 20, 2027
Last Updated
11 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marian L Dale, MD

Associate Professor of Neurology, School of Medicine; Director, OHSU CurePSP Center of Care

Oregon Health and Science University

Eligibility Criteria

Inclusion Criteria

  • probable or possible PSP by the revised MDS PSP Criteria (Hoglinger 2017)
  • age 40-85 at time of screening
  • ability to understand and cooperate with simple instructions in English
  • ability to read at 6th grade reading level in English
  • ability to stand unassisted for at least 30 seconds and to be able walk independently with a walker
  • ability to refrain from new physical and speech therapy programs for the duration of the study
  • ability to remain on stable doses of any cholinergic, dopaminergic, serotonergic sedative or NMDA receptor antagonists for the duration of the study
  • females of child-bearing age must perform a urine pregnancy test and be on reliable birth control during the course of the study

Exclusion Criteria

  • other significant neurological or vestibular disorders
  • presence of electrically, magnetically or mechanically activated implants or history of injurious metal exposure in eyes, head, or body

Outcomes

Primary Outcomes

objective posturography

Time Frame: assessed on 4 days during the 8 week study period

The primary endpoint is center of pressure shifts with tilt and with translation, and body sway in quiet stance.

Secondary Outcomes

  • fNIRS(assessed on 4 days during the 8 week study period)
  • speech analysis(assessed on 4 days during the 8 week study period)

Study Sites (1)

Loading locations...

Similar Trials